Vetoquinol
 
公司簡況
財務
派息紀錄
盈利預測
股權變動
ETF簡況
 
 
 
公司概覽
業務類別 --
業務概覽 Vetoquinol SA operates is a France-based firm serving in the healthcare market. Its focus lies on developing and marketing veterinary drugs mainly in the European region and to a certain extent in America and Asia. Its portfolio of drugs entails anti-infectives, anti- pain inflammatory drugs, cardiovascular and nephrology treatment intended mainly for pets and livestock.
公司地址 Magny-Vernois, BP 189, Lure cedex, FRA, 70204
電話號碼 +33 384625555
傳真號碼 +33 384625556
公司網頁 http://www.vetoquinol.com
員工數量 2132
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Matthieu Frechin Director and Chief Executive Officer -- 25/04/2024
 
董事會成員
董事會 職務 更新日期
Ms. Anne-Marie Graffin Independent Director 25/04/2024
Ms. Audrey Chanoinat Director 25/04/2024
Mr. Luc Frechin Director 25/04/2024
Mr. Etienne Frechin Chairman of the Board 25/04/2024
Mr. Matthieu Frechin Director and Chief Executive Officer 25/04/2024
Mr. Philippe Arnold Independent Director 25/04/2024
Mr. Louis Champel Independent Director 25/04/2024
Ms. Marie-Josephe Baud Independent Director 25/04/2024
 
所屬ETF (更新日期: 07/03/2026 03:15)
代號 名稱 佔比% ▼ 持有日期
DFISDimensional International Small Cap ETF0.04%27/02/2026
DFICDimensional International Core Eq 2 ETF0.02%27/02/2026
DFAXDimensional World ex US Core Eq 2 ETF0.01%27/02/2026
SPEUState Street® SPDR® Portfolio Europe ETF0.001%27/02/2026
DFAIDimensional International Cr Eq Mkt ETF0.001%27/02/2026
DFSIDimensional International Sstby Cr 1 ETF0.001%27/02/2026
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.